TekCyte
Company

date founded

General

About Company
TekCyte is a world leader in developing and manufacturing advanced coatings for medical devices and biomedical applications.

Industry

Sector :

Subsector :

Number of employees

Company Type

For Profit

IPO status

Private

Description

TekCyte specializes in the development and production of advanced coatings for medical devices and biomedical applications. As a leading company in the industry, TekCyte is known for its expertise in creating innovative coatings that enhance the performance and functionality of medical devices. These coatings are designed to improve the biocompatibility, durability, and functionality of various medical devices, ranging from implants to diagnostic tools. With a focus on research and development, TekCyte continuously works towards advancing the field of medical device coatings, providing solutions that meet the evolving needs of the healthcare industry.
Contacts

Contact Email

Phone number

Social url

Similar Companies
111
Hemoteq

Hemoteq

Hemoteq AG develops innovative coating solutions for medical devices.

Sector

Chemicals

Subsector

Specialty Chemicals

Keywords

Medical Device, Manufacturing, Health Care

Location

52146 Würselen, Germany

total rounds

3

Angtrom Medica

Angtrom Medica is a biomaterials and medical device company specializing in nanocrystalline calcium phosphate technology.

Sector

Chemicals

Subsector

Specialty Chemicals

Keywords

Biotechnology, Health Care, Medical

Location

Woburn, MA, USA
Accord Biomaterials

Accord Biomaterials

Accord Biomaterials develops chemistries and coatings for medical device protection.

Sector

Chemicals

Subsector

Specialty Chemicals

Keywords

Medical Device, Health Care, Chemical

Location

Ann Arbor, MI, USA

total rounds

1

total raised

$1.2M
Biocoat

Biocoat

Biocoat develops custom biomaterial coatings for medical devices.

Sector

Chemicals

Subsector

Specialty Chemicals

Keywords

Manufacturing, Medical Device, Biotechnology

Location

Horsham, PA, USA

total rounds

1

Financials

Co-Investors

Activity

Recent News
0